Skip to content

ECO.PHARMA.SUPPLY

Active
Private limited companyfounded 2013active for 12 yearsPorte des Bâtisseurs(EST) 18, 7730 Estaimpuis, BelgiumKBO/BCE: BE 0543.602.945
Summary

The computed 12-month bankruptcy probability of ECO.PHARMA.SUPPLY is 1.8% (moderate). The annual accounts of ECO.PHARMA.SUPPLY for financial year 2025 show a net loss of 68% of the equity at the start of that year. The 2025 annual accounts show equity of €159,479 and a net result of -€337,585. Equity remains stable across the filed financial years (±2.4% per year). Its solvency ranks better than 19% of 5,007 sector peers (NACE 47, financial year 2025). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
ECO.PHARMA.SUPPLYActiveChecked score 52/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Wholesale of pharmaceutical and medical goods NACE 46460
3 sites
Size
€2.0mtotal assets 2025
Staff
6.8 FTE
Equity
€159,479
Loss
-€337,585
Financial health
52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.8%
Structure
Parent
MEDIGROUP · 100%
Holdings
1
Auditor: EY Bedrijfsrevisoren BV2025 accounts 32 days early5 of 11 deeds summarised
Why 52raises riskLoss of €337,585 (financial year 2025)Equity €159,479 (7.9% of total assets)Sector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.08, cash €447,204Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 16% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 33-9
equity 7.9% of total assets
Liquidity 28+14
short-term debt 92.1% · cash 22.3%
Profitability 0-33
return on assets -16.8%
Bankruptcy probability, 12 months
1.8% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: 1.0% 12-2024: 0.9%▼ -0.1 percentage points vs 11-2024 01-2025: 0.9%● unchanged vs 12-2024lowest value 02-2025: 0.9%● unchanged vs 01-2025 03-2025: 0.9%● unchanged vs 02-2025 04-2025: 0.9%● unchanged vs 03-2025 05-2025: 0.9%● unchanged vs 04-2025 06-2025: 1.0%▲ +0.1 percentage points vs 05-2025 07-2025: 1.3%▲ +0.3 percentage points vs 06-2025 08-2025: 1.0%▼ -0.3 percentage points vs 07-2025 09-2025: 1.0%● unchanged vs 08-2025 10-2025: 0.9%▼ -0.1 percentage points vs 09-2025 11-2025: 0.9%● unchanged vs 10-2025 12-2025: 0.9%● unchanged vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.9%● unchanged vs 01-2026 03-2026: 1.0%▲ +0.1 percentage points vs 02-2026 04-2026: 1.2%▲ +0.2 percentage points vs 03-2026 05-2026: 1.2%● unchanged vs 04-2026 06-2026: 1.3%▲ +0.1 percentage points vs 05-2026 07-2026: 1.4%▲ +0.1 percentage points vs 06-2026 08-2026: 2.5%▲ +1.1 percentage points vs 07-2026 09-2026: 2.9%▲ +0.4 percentage points vs 08-2026highest value 10-2026: 1.8%▼ -1.1 percentage points vs 09-2026
Credit of up to €8,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity tight (current ratio 1.08, compared with 1.2 in 2024, below the usual 1.5; short-term debt: 92.1% and cash: 22.3% of total assets), and 92.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 25% on solvency, 25% on liquidity, 6% on profitability and 8% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Loss of €337,585 (financial year 2025)
NBB · annual accounts
raises risk · Equity €159,479 (7.9% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.08, cash €447,204
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 5007 sector peers (2025).
NBB · sector comparison
Position among 5007 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
32 days early
2024
22 days early
2023
26 days early
2022
8 days late
2021
30 days early
2020
32 days early
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 19 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 July (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Deloitte Bedrijfsrevisoren (statutory auditor)Appointment: EY Bedrijfsrevisoren BV (statutory…
  2. Annual accounts filedfinancial year 2025 · full…
  3. Weakest financial yearnet -€337,585

Key points

  • Caution: From profit to loss in 2025after €62,008 in 2024 -€337,585 View
  • Caution: Among the weakest 5% on net resultsector median €40,191 · 5,007 companies -€337,585 View
  • Controlled by MEDIGROUPultimately: A.forall Group 100% View

By topic

Financials

Financial year
2025
Total assets
€2.0m
Loss
-€337,585
Solvency
7.9%
Total assets▼ 31.2%
Net result
20192025
Go to Financials

Timeline

Events
18
Since
2016
Next accounts
by 31-07-2027
  1. 30-10-2025Resignations: Themtis BV (director) and LMDC GmbH…
  2. 15-09-2025Reappointment: Deloitte Bedrijfsrevisoren SRL (commissaire aux comptes)
  3. 09-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
3
Legal form
Private limited company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
26-12-2013
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about ECO.PHARMA.SUPPLY

What is the company number of ECO.PHARMA.SUPPLY?
0543.602.945. In Belgium the VAT number is the company number with BE in front: BE 0543.602.945.
Where is ECO.PHARMA.SUPPLY based?
The registered office is at Porte des Bâtisseurs(EST) 18, 7730 Estaimpuis.Company details
What does ECO.PHARMA.SUPPLY do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of ECO.PHARMA.SUPPLY?
Private limited company (BV).
When was ECO.PHARMA.SUPPLY founded?
On 26-12-2013.
Is ECO.PHARMA.SUPPLY still active?
Yes, ECO.PHARMA.SUPPLY is an active enterprise in the KBO register.
How many employees does ECO.PHARMA.SUPPLY have?
On average 6.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of ECO.PHARMA.SUPPLY?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is ECO.PHARMA.SUPPLY profitable?
In financial year 2025, ECO.PHARMA.SUPPLY made a loss of €337,585.
Where can I find the annual accounts of ECO.PHARMA.SUPPLY?
ECO.PHARMA.SUPPLY filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ECO.PHARMA.SUPPLY due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to ECO.PHARMA.SUPPLY

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Which other companies belong to the same group?A.forall Group · 9 companies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure